Top-News
Professionelle Dienstleistungen USA

Medical Marijuana Inc News

Aktie
WKN:  A1C63S ISIN:  US58463A1051 US-Symbol:  MJNA
0,0018 $
-0,0001 $
-5,26%
31.05.24 21:20:09
Handeln Depot/Watchlist
Aktienanzahl *
3,16 Mrd.
Marktkapitalisierung *
5,24 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 04.03.2024

Medical Marijuana Inc News

15.03.24 - PR Newswire
Thinking about buying stock in Inpixon, Medical Marijuana, Hello Group, Vroom, or Heritage Insurance Holdings?
Thinking about buying stock in Inpixon, Medical Marijuana, Hello Group, Vroom, or Heritage Insurance Holdings? PR Newswire
26.10.21 - DGAP
Kannaway(R), eine Tochtergesellschaft von Medical Marijuana, Inc., gewinnt Verfahren am obersten Verwaltungsgericht zum legalen Import von CBD-Öl nach Finnland
DGAP-News: Medical Marijuana, Inc. / Schlagwort(e): Rechtssache Kannaway(R), eine Tochtergesellschaft von Medical Marijuana, Inc., gewinnt Verfahren am obersten ...
06.07.20 - PR Newswire
Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Announces June 2020 as the Largest Sales Bookings Month in Company History
Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Announces June 2020 as the Largest Sales Bookings Month in Company History PR Newswire
01.07.20 - PR Newswire
Medical Marijuana, Inc. Reports 2020 First Quarter Financial and Operational Results
Medical Marijuana, Inc. Reports 2020 First Quarter Financial and Operational Results PR Newswire
30.06.20 - PR Newswire
Medical Marijuana, Inc. Subsidiary HempMeds® Co-CEO Caroline Heinz Featured in Yahoo! Finance
Medical Marijuana, Inc. Subsidiary HempMeds® Co-CEO Caroline Heinz Featured in Yahoo! Finance PR Newswire
23.06.20 - PR Newswire
Medical Marijuana, Inc. Subsidiary HempMeds® Co-CEO Raul Elizalde Invited to Speak on Expert Panel About Cannabis in Mexico
Medical Marijuana, Inc. Subsidiary HempMeds® Co-CEO Raul Elizalde Invited to Speak on Expert Panel About Cannabis in Mexico PR Newswire
11.06.20 - PR Newswire
Medical Marijuana, Inc. Subsidiary HempMeds® Co-CEOs Invited to Speak at The Global Cannabis Summit Virtual Conference
Medical Marijuana, Inc. Subsidiary HempMeds® Co-CEOs Invited to Speak at The Global Cannabis Summit Virtual Conference PR Newswire
04.06.20 - PR Newswire
Medical Marijuana, Inc. Investment Company Kannalife, Inc. Appoints Terrence O. Tormey to Board of Advisors
Medical Marijuana, Inc. Investment Company Kannalife, Inc. Appoints Terrence O. Tormey to Board of Advisors PR Newswire
28.05.20 - PR Newswire
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Expands Research Division and Announces Dr. Sergei Svarovsky as Chief Scientific Officer of Subsidiary Sapphire Biotech
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Expands Research Division and Announces Dr. Sergei Svarovsky as Chief Scientific Officer of Subsidiary ...
22.05.20 - PR Newswire
Medical Marijuana, Inc. Subsidiary Kannaway® Welcomes Leading Network Marketer Daniele Paiola Bellucci to the Company
Medical Marijuana, Inc. Subsidiary Kannaway® Welcomes Leading Network Marketer Daniele Paiola Bellucci to the Company PR Newswire
21.05.20 - PR Newswire
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Files Patent for Unique Early Detection Cancer Biomarker
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Files Patent for Unique Early Detection Cancer Biomarker PR Newswire
19.05.20 - PR Newswire
Medical Marijuana, Inc. and Subsidiaries Kannaway® and HempMeds® Honored as Stevie® Award Winners in 2020 American Business Awards®
Medical Marijuana, Inc. and Subsidiaries Kannaway® and HempMeds® Honored as Stevie® Award Winners in 2020 American Business Awards® PR Newswire
11.05.20 - PR Newswire
Medical Marijuana, Inc. Subsidiary Kannaway® Launches First-Ever CBD Fitness Program
Medical Marijuana, Inc. Subsidiary Kannaway® Launches First-​Ever CBD Fitness Program PR Newswire
07.05.20 - PR Newswire
Medical Marijuana, Inc. Names Caroline Heinz and Raul Elizalde Co-CEOs of Subsidiary HempMeds®, Appoints Todd Morrow to Chief Information Officer
Medical Marijuana, Inc. Names Caroline Heinz and Raul Elizalde Co-CEOs of Subsidiary HempMeds®, Appoints Todd Morrow to Chief Information Officer PR Newswire
05.05.20 - PR Newswire
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Files New U.S. Patent Application for Water-Soluble Cannabinoid Molecules
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Files New U.S. Patent Application for Water-​Soluble Cannabinoid Molecules PR Newswire
29.04.20 - PR Newswire
Medical Marijuana, Inc. Reports 2019 Fourth Quarter and Year-End Financial and Operational Results: Net Revenue Surpasses $75 Million, Increasing 26% Year-Over-Year and Positive Adjusted EBITDA
Medical Marijuana, Inc. Reports 2019 Fourth Quarter and Year-End Financial and Operational Results: Net Revenue Surpasses $75 Million, Increasing 26% Year-​Over-Year and ...
22.04.20 - PR Newswire
Medical Marijuana, Inc. Subsidiary Kannaway® Promotes Janne Heimonen to Company's Managing Director of International
Medical Marijuana, Inc. Subsidiary Kannaway® Promotes Janne Heimonen to Company's Managing Director of International PR Newswire
14.04.20 - PR Newswire
Medical Marijuana, Inc. Subsidiary Kannaway® Promotes Stephen Jones to President
Medical Marijuana, Inc. Subsidiary Kannaway® Promotes Stephen Jones to President PR Newswire
09.04.20 - PR Newswire
Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Receives Notice of Allowance from USPTO for Trademark of Atopidine™
Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Receives Notice of Allowance from USPTO for Trademark of Atopidine™ PR Newswire
08.04.20 - PR Newswire
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Receives New U.S. Patent Issuance for Chewing Gum Comprising Cannabinoids and Nicotine
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Receives New U.S. Patent Issuance for Chewing Gum Comprising Cannabinoids and Nicotine PR Newswire

Newssuche

Videos

29.05.24 +24,01%
Technical Trading: DAX Long Chance kurzfristig
DAX Long Typ: Turbo Open End WKN: VD5FWS Hebel: 28 Laufzeit: OpenEnd Einstieg: Market ... Mehr »